CDIO stock icon

Cardio Diagnostics
CDIO

$0.69
1.86%
 

About: Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

Employees: 9

0
Funds holding %
of 6,665 funds
Analysts bullish %
0
News positive %
of 3 articles

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

0% more funds holding

Funds holding: 14 [Q4 2023] → 14 (+0) [Q1 2024]

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.17% less ownership

Funds ownership: 8.07% [Q4 2023] → 7.9% (-0.17%) [Q1 2024]

44% less capital invested

Capital invested by funds: $4.12M [Q4 2023] → $2.3M (-$1.82M) [Q1 2024]

Research analyst outlook

1 Wall Street Analyst provided 1 year price forecasts over the past 6 months

Low target
$1.35
97%
upside
Avg. target
$1.35
97%
upside
High target
$1.35
97%
upside

1 analyst rating

positive
100%
neutral
0%
negative
0%
Benchmark
Bruce Jackson
97%upside
$1.35
Speculative Buy
Maintained
19 Apr 2024

Financial journalist opinion

Based on 3 articles about CDIO published over the past 30 days